Cholesterol-lowering drug targets reduce risk of dementia: Mendelian randomization and meta-analyses of 1 million individuals. - Nordestgaard LT; Hanson A; Sanderson E; Anderson E; Walker V; Tybjærg-Hansen A; Smith GD; Nordestgaard BG (Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025)